The COVID-19 pandemic has thrown a wrench into every corner of the American healthcare system, and clinical research is no exception. In light of physical distancing and public safety recommendations, research programs have made significant adjustments, including virtual approaches to site selection and data collection and increased use of telehealth services. What lessons about clinical research can be learned during the pandemic, and what does it mean for the future of cancer research?

On Wednesday, February 10, join a discussion on the impact of COVID-19 on cancer research protocols and patients’ experiences. An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic, review available guidance, and look at how current adaptations can be made more sustainable in post-pandemic research.

Speakers:

• Al B. Benson III, MD, FACP, FASCO, Professor of Medicine; Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center of Northwestern University 
• Jennie R. Crews, MD, MMM, FACP, Medical Director, Research Integration and SCCA Network, Seattle Cancer Care Alliance; Associate Clinical Professor, University of Washington School of Medicine 
• Randall A. Oyer, MD, Medical Director, Oncology Program, Penn Medicine Lancaster General Health; 2020-21 ACCC President (MODERATOR) 

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the webcast.

This webcast is part of the 2020-2021 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research. This important work includes monthly research newsletter, a series of webcasts on research-related topics of interest, blog posts, and additional resources.
Register